Previously reporting to the CEO of Modern Meadow, a biotechnology startup, currently heads ESG to drive Modern Meadow’s ESG strategy to ensure that sustainability is an integral aspects of company’s business strategy and a clear differentiator in the market. Responsible for a broad range of activities, including, but not limited to, ensuring alignment of our ESG strategy with our corporate strategy, embedding our ESG vision into our functional areas and capabilities, engaging with both internal (e.g., Impact Committee, Impact Advisory Board, BOD, etc.) and external stakeholders (e.g., investors, ratings agencies) to advance our ESG performance and impact, and to convey our narrative by leading the publication of the company’s annual ESG reporting process working in partnership with our finance and corporate audit functions. Prior to the current role, headed the sustainability strategy and implementation work at Teva which included co-leading the work to issue $5B SLB enabled by the decarbonization 2030 targets and KPIs.  Prior to Teva, lead the industry engagement work for ACS Green Chemistry Institute (GCI) to promote and advance green chemistry across global society.